Effect Of Palbociclib (Pal) Plus Endocrine Therapy (Et) On Time To Chemotherapy (Ttc) Across Subgroups Of Patients (Pts) With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (Hr+/Her2-) Advanced Breast Cancer (Abc): Post Hoc Analyses From Paloma-2 (P2) And Paloma-3 (P3)